Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Biotech Investing
On this Biotech Investing tag page, 5 recent articles cover innovative biotech stocks, Agios moves, Arcellx updates, Cogent Biosciences and more, giving you quick, actionable finance insights.
109 articlesLigand (LGND) 2026 Earnings Outlook for Investors
Get a clear, real-world view of Ligand (LGND) 2026 earnings. This guide breaks down revenue sources, milestones, and ...
Abcellera (ABCL) 2026 Earnings Outlook for Investors
Abcellera's Q1 2026 earnings transcript provides key clues about the path to 2026. This guide breaks down revenue dri...
Capricor's Insider Just Sold: Read the Signals for Investors
When a top Capricor executive liquidates stock, investors want to know what it means. This guide breaks down the trad...
Structure Therapeutics Stock 47% Jump: What It Means
A sudden 47% rise in Structure Therapeutics stock has traders buzzing while a major fund exits a multi-million dollar...
Delcath (DCTH) 2026 Earnings Outlook: What Investors Need
Biotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
PacBio (PACB) 2026 Earnings: Insights & Investment Outlook
As PacBio lays out its Q1 2026 results, investors hunt for catalysts, cadence, and cash runway signals. This guide tr...
BridgeBio (BBIO) 2026 Earnings: Practical Investor Guide
BridgeBio's Q1 2026 earnings narrative is more than quarterly numbers—it's a roadmap for the year ahead. This guide e...
Is This Biotech Stock After Groundbreaking Approval?
A breakthrough approval can move a biotech stock in dramatic ways. This guide breaks down how to assess the upside, m...
Evaxion (EVAX) 2026 Earnings: A Clear Commercial Outlook
Evaxion's Q1 2026 results shed light on how its AI-driven drug discovery model is translating into collaborations and...
Biocryst (BCRX) 2026 Earnings: What Investors Should Know
BioCryst faces a pivotal year. This practical guide breaks down what biocryst (bcrx) 2026 earnings could mean for inv...
Wave Life Sciences Slips as Obesity Data Falls Short
Wave Life Sciences slumped after INLIGHT readouts failed to establish WVE-007 as a solo obesity treatment, triggering...
Related Topics
#Stock Analysis (25)
#Earnings Analysis (22)
#Portfolio Management (15)
#Portfolio Strategy (13)
#Stock Market (12)
#Investing (10)
#Insider Trading (10)
#risk-management (8)
#Hedge Funds (7)
#Earnings (5)
#Healthcare Stocks (5)
#SEC Filings (5)
#Investment Strategy (4)
#Stock Market News (4)
#Small-Cap Stocks (4)